Webinar: Supplier Development: Turning Weak Suppliers into Strategic Partners

Register Now

Discover your potential savings with our ROI Calculator

Calculate ROI now
  Medical device  >  PMS Software

Post-Market Surveillance Software for Medical Devices

Manufacturers need continuous visibility into medical device performance, safety, and compliance after products reach the market.

PMS Software centralizes complaints, adverse events, CAPA, risk signals, and regulatory reporting to support compliance with FDA, EU MDR, and other global post-market surveillance requirements.

Request Demo
Post Market Surveillance Software for Medical Devices
Online Demo

Please confirm your details

PMS Process for Medical Devices

What is the PMS Process for Medical Devices?

The Post-Market Surveillance (PMS) process for medical devices is a critical regulatory requirement designed to ensure ongoing safety and effectiveness of devices after they have been marketed.

It involves systematically collecting, analyzing, and interpreting data about a device’s performance and adverse events. Manufacturers must develop a comprehensive PMS plan, which includes gathering end-user feedback, monitoring clinical results, and reviewing scientific literature. Issues identified through PMS may lead to corrective actions, such as updating the product, enhancing training, or even recalling a device. Results from PMS activities must be documented and reported to regulatory authorities to comply with legal obligations and support continuous improvement of the device.

Trusted by Leading Organizations

adicet-bio-logo
dialight-logo
empower-pharmacy-logo
flex-logo
new-age-industries-logo
origen-logo
paragon-logo
sensitech-logo
solius-logo
tilray-logo
ykk-logo

What are the Responsibilities of Post-Market Surveillance Medical Devices?

Post-Market Surveillance (PMS) of medical devices is critical to maintaining patient safety and device efficacy throughout the product lifecycle. The responsibilities involved in PMS include:

Responsibilities of Post-Market Surveillance Medical Devices
  • Monitoring and Reporting: Continuously monitor the performance and safety of medical devices after they have been launched. This includes collecting and evaluating data from various sources, such as clinical use reports, feedback from healthcare professionals and patients, and literature reviews.
  • Adverse Event Reporting: Systematically capturing, investigating, and reporting adverse events and other incidents to regulatory authorities in compliance with local laws and regulations. This helps identify potential safety issues that may not have been apparent during the pre-market phase.
  • Risk Management: Updating the risk management process based on post-market data and experiences to mitigate any emerging risks associated with the device.
  • Corrective Actions: Implementing corrective actions when necessary, such as device modifications, recalls, or issuing safety alerts to manage any risks identified during the post-market phase.
  • Performance Reviews: The collected data should be reviewed regularly to assess the device’s benefit-risk balance and ensure continued compliance with regulatory requirements.
  • Documentation and Reporting: Maintain detailed records of all surveillance activities and report findings to regulatory authorities and other stakeholders as required.

Strengthen Your Medical Device Post-Market Surveillance Process

Streamline PMS activities with a centralized platform for complaint handling, adverse event reporting, risk monitoring, CAPA, and regulatory compliance.

Explore PMS Software
ai-based-capa-management-personalized-demo

Importance of Post-Market Surveillance under EU MDR for Patient Safety and Compliance

  • Early detection of safety issues: Traditional pre-market testing has limitations and may miss real-world problems. PMS actively gathers data from healthcare professionals and patients, allowing earlier identification of potential risks and adverse events before they harm more individuals.
  • IProactive risk mitigation: Once identified, potential issues can be addressed promptly through corrective and preventive actions (CAPAs), like device modifications, updated instructions, or safety warnings. This proactive approach helps minimize patient harm and prevent future occurrences.
  • Improved device performance: PMS data provides valuable insights into device performance in real-world settings, identifying areas for improvement and driving continuous innovation to enhance overall device effectiveness and patient outcomes.
  • Demonstrates commitment to patient safety: Effective PMS showcases a manufacturer's proactive efforts to ensure device safety and compliance with the MDR's rigorous requirements. This commitment builds trust with regulatory authorities and healthcare professionals.
  • Reduces regulatory risk: Proactively identifying and mitigating risks through PMS can prevent costly regulatory actions like product recalls or fines for non-compliance, significantly reducing financial and reputational risks.
  • Contributes to regulatory oversight: PMS data contributes to the broader knowledge base on medical device safety, informing regulatory decisions and potentially leading to improved standards and requirements for future devices.
Rental Equipment Companies
Whitepaper

From Risk to Resilience: A Practical Guide to Prevent Medical Device Recalls

Rental Equipment Companies
Case Study

ComplianceQuest Medical Devices QMS Success Stories eBook

Rental Equipment Companies
Whitepaper

Always Audit Ready vs. Scrambling Before Audits: How Smart Med Device Teams Maintain a Competitive Edge

A Step-by-Step Guide to Implement Post-Market Surveillance under EU MDR

Here's a guide on how to effectively implement PMS under EU MDR:

Step-by-Step Guide to Implement Post-Market Surveillance under EU MDR

  • Understand Regulatory Requirements: Familiarize yourself with the PMS requirements outlined in EU MDR. This includes understanding the obligations of continuous monitoring, reporting, and updating information for your medical devices.
  • Establish a PMS System: Develop a robust PMS system tailored to your organization's structure and devices. Define roles and responsibilities for individuals involved in PMS activities.
  • Develop a PMS Plan: Create a comprehensive PMS plan outlining data collection, analysis, and reporting strategies. Define the methodologies for risk assessments and benefit-risk evaluations.
  • Implement Data Collection Mechanisms: Set up effective mechanisms for collecting data from various sources, including customer feedback, complaints, adverse events, and clinical investigations. Establish a system for collecting and analyzing real-world device performance and safety data.
  • Utilize Post-Market Clinical Follow-Up (PMCF): Implement PMCF activities as part of your PMS plan to gather additional clinical data post-market. Regularly review and update PMCF plans based on emerging data.
  • Monitor Complaints and Adverse Events: Establish a systematic approach to monitor and manage complaints and adverse events. Implement a standardized process for documenting, investigating, and reporting incidents.
  • Implement Trend Analysis: Utilize data analytics to identify trends and patterns in reported incidents. Regularly conduct trend analyses to address potential issues proactively.
  • Communication and Reporting: Establish clear communication channels internally and externally for reporting incidents. Comply with reporting timelines outlined in EU MDR for serious incidents and trends affecting patient safety.
  • Continuous Improvement: Implement a culture of continuous improvement based on PMS findings. Regularly update risk management documentation and take corrective actions as needed.

Here is a checklist for a Post-Market Surveillance (PMS) Plan for Medical Device Manufacturers under EU MDR.

Request CQ Medical Device PMS Demo

What is the Difference Between Pharmacovigilance and Post-Marketing Surveillance?

Pharmacovigilance and Post-Market Surveillance (PMS) are both crucial processes in monitoring the safety and effectiveness of health products after they have been released to the market, but they focus on different types of products and involve distinct activities:

Comparison Criteria

Pharmacovigilance:

  • Scope: Specifically pertains to pharmaceuticals, including prescription drugs, over-the-counter medications, and biologics.
  • Purpose: To detect, assess, understand, and prevent adverse effects or other drug-related problems.
  • Activities: Collecting and analyzing adverse drug reaction reports from healthcare providers, patients, and other stakeholders. Pharmacovigilance also involves evaluating patient safety data from clinical trials, literature reviews, and databases to identify new information about hazards associated with drug products.

Post-Market Surveillance (PMS)

Post-Market Surveillance (PMS):

  • Scope: Broadly applicable to medical devices, from simple devices like bandages to complex technologies like pacemakers.
  • Purpose: To ensure ongoing safety and effectiveness of the device across its lifecycle and to detect any potential device-related failures or adverse events.
  • Activities: PMS involves collecting data from various sources, including customer feedback, clinical studies, and the analysis of returned products. It may also involve corrective actions such as recalls, safety alerts, or modifications to the device or its labeling.
Request an Online Demo
Comparison Criteria Pharmacovigilance Post-Market Surveillance (PMS)
Scope Specifically pertains to pharmaceuticals, including prescription drugs, over-the-counter medications, and biologics. Broadly applicable to medical devices, from simple devices like bandages to complex technologies like pacemakers.
Purpose To detect, assess, understand, and prevent adverse effects or other drug-related problems. To ensure ongoing safety and effectiveness of the device across its lifecycle and to detect any potential device-related failures or adverse events.
Activities Collecting and analyzing adverse drug reaction reports from healthcare providers, patients, and other stakeholders. Pharmacovigilance also involves evaluating patient safety data from clinical trials, literature reviews, and databases to identify new information about hazards associated with drug products. PMS involves collecting data from various sources, including customer feedback, clinical studies, and the analysis of returned products. It may also involve corrective actions such as recalls, safety alerts, or modifications to the device or its labeling.

Both pharmacovigilance and post-market surveillance are integral to regulatory compliance. They are designed to protect public health by ensuring that the benefits of drugs and medical devices continue to outweigh their risks after they reach the market.

ISO 13485 also plays a role in post-marketing surveillance. The standard focuses on ensuring the safety and quality of medical devices throughout their lifecycle.

Related Assets


Related Checklists

Quality-centric Companies Rely on CQ QMS

  • Flex
  • continental
  • 3m logo
  • YKK
  • Qorvo
  • Canon
  • Stryker
  • Lam Research
  • Just Evotech
  • Tilray

Frequently Asked Questions

  • An example of Post-Market Surveillance (PMS) involves a manufacturer of cardiac stents. After their stents are released onto the market, the manufacturer actively monitors their performance through various PMS activities. This includes collecting data from hospitals and clinics on the rate of complications such as stent thrombosis or restenosis. They also gather feedback from cardiologists and patients regarding the device's efficacy and any adverse events experienced.

    Additionally, the manufacturer regularly reviews scientific literature and participates in clinical registries to compare their stents' performance against others in the market. Based on the outcomes, the manufacturer may update the device's labeling, provide additional training to healthcare providers, or make design modifications. They report these findings and corrective actions to regulatory authorities to ensure compliance and maintain public trust in their product.

Mascot Astronut

Related Insights

Navigating QMSR, ISO 9001 Updates, and AI Integration: What Quality Leaders Should Focus on Next
Blog | June 12th, 2026

Navigating QMSR, ISO 9001 Updates, and AI Integration: What Quality Leaders Should Focus on Next

Recently, I had the opportunity to present a webinar with Quality Magazine, on the topic: “Navigating QMSR, ISO 9001 Updates, and…

View All Resources

Connect with a CQ Expert

Learn about all features of our Product, Quality, Safety, and Supplier suites. Please fill the form below to access our comprehensive demo video.

Mascot

Please confirm your details

In Need of Smarter Ways Forward? Get in Touch.

Get a Demo Today
×
spinner
Consult Now

Comments